Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS

Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS

BACKGROUND Whether airspace biomarkers add value to plasma biomarkers in studying acute respiratory distress syndrome (ARDS) is not well understood. Mesenchymal stromal cells (MSCs) are an investigational therapy for ARDS, and airspace biomarkers may provide mechanistic evidence for MSCs’ impact in...

Full description

Bibliographic Details
Main Authors: Katherine D. Wick, Aleksandra Leligdowicz, Hanjing Zhuo, Lorraine B. Ware, Michael A. Matthay
Format: Article
Language:English
Published: American Society for Clinical investigation 2021-06-01
Series:JCI Insight
Subjects:
Pulmonology
Stem cells
Online Access:https://doi.org/10.1172/jci.insight.148983

Similar Items

Similar Items